MedPath

Therapie Resistentie Voorspellen bij Schizofrenie

Recruiting
Conditions
Schizophrenia, treatment resistance, psychosis, schizofrenie, therapie resistentie, psychose
Registration Number
NL-OMON21525
Lead Sponsor
Amsterdam UMC, University of Amsterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

First episode psychosis

- Age 18-35 years old

Exclusion Criteria

- Antipsychotic use longer than one year

- Dependence on other substances of abuse than nicotine or cannabis

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
- Treatment resistance<br /><br>- Neuromelanin contrast ratio on nMRI<br /><br>- Glutamate/Creatine ratio on MRS in ACC<br /><br>- Plasma DDC activity<br /><br>- [18F]F-DOPA influx (Ki) value (for subgroup of 40 patients)<br>
Secondary Outcome Measures
NameTimeMethod
- Side effects of antipsychotics<br /><br>- Symptom scores on PANSS<br /><br>- Neuropsychological ratings<br>
© Copyright 2025. All Rights Reserved by MedPath